Zofran Birth Defects Lawsuit | Zofran Lawsuit
Zofran Birth Defects, Zofran Birth Defects Lawsuit | Zofran Cleft lip Lawsuit, Zofran Cleft Palate Lawsuit, Zofran Heart Defects Lawsuit | Birth Defects: Cleft lip, Cleft palate, Heart defects, including atrial and ventricular septal defects | Ondansetron Birth Defect Lawsuit
Did you have a child with a serious birth defect after using Zofran ( Ondansetron ) to control severe morning sickness during your pregnancy? According to one recent analysis, one million expectant mothers in the U.S. are prescribed Zofran every year, unaware that its safety during pregnancy had never been well evaluated. Zofran birth defect lawsuits are now mounting in U.S. courts, all of which accuse GlaxoSmithKline of promoting the anti-nausea drug as a morning sickness remedy even though it has never been approved for this use. You could be eligible to file a similar claim if your child suffered any of these problems that may be related to prenatal Zofran exposure:
- Cleft lip
- Cleft palate
- Heart defects, including atrial and ventricular septal defects
- Kidney abnormalities
- Musculoskeletal deformities
- Poor fetal growth
- Fetal death
As both an attorney and practicing physician, Dr. François Blaudeau possesses a unique understanding of the medical and legal questions at issue in a Zofran birth defects lawsuit. To learn more about your legal rights and fro a FREE Zofran birth defects lawsuit review please call Southern Med Law as soon as possible for a free, no-obligation case review.
Zofran and Birth Defects
Zofran has been on the market since 1991, and in that time it has only been approved to treat nausea and vomiting experienced by post-operative surgery patients, or those undergoing certain chemotherapy and radiation treatments in cancer patients. Zofran’s listing in Pregnancy Category B indicates that its effects on a developing fetus are not well studied.
Unfortunately, this did not stop GlaxoSmithKline from promoting the drug as an off-label treatment for severe morning sickness, or hyperemesis gravidarum. In 2012, the company reached a $3 billion settlement with the U.S. Department of Justice, which had accused the drug maker of, among other things, illegally marketing Zofran for morning sickness and paying kickbacks to doctors who prescribed the for such purposes.
Zofran Sudies Regarding The Use Of Zofran In The First Trimester and Birth Defects
Recently, a number of studies have raised concern that Zofran may cause birth defects when it is used to treat pregnant women, especially if they are exposed to the drug during their first trimester. In 2013 research based on 900,000 births from a Danish registry found a 30% increased risk of birth defects overall, and a doubled risk of heart defects. Just a year earlier, the Center for National Birth Defects Research and Prevention identified a 2.4-fold increased risk for cleft palate and cleft lip among children born to women who were treated with Zofran during their first trimester. In 2014, a study published by Swedish researchers linked Zofran to an increased risk of heart defects, especially cardiac septum defects.
A growing number of Zofran birth defects lawsuits have been filed on behalf of children who allegedly suffered heart defects, oral clefts, and other serious birth defect due to prenatal exposure to the drug. Among other things, plaintiffs allege that Glaxo has received numerous reports of Zofran-related birth defects since 1991, but has concealed that information from the public and medical community.
Legal Help for Victims of Zofran Birth Defects And Help In Filing A Zofran Birth Defects Lawsuit
Having a child with a severe birth defect can be emotionally and financially devastating for the entire family. With Dr. François Blaudeau and the legal staff of Southern Med Law on your side, you can be confident that every step will be taken to hold GlaxoSmithKline accountable. Please don’t hesitate! If you would like to arrange for a free, no-obligation Zofran birth defects lawsuit review, simply call Southern Med Law today at 205-547-5525, or fill out the online form on this page.